ArticleInvestigative ophthalmology & visual science2026
The Matricellular Protein CCN1 Induces Corneal Stromal Cells Senescence and Inflammation to Trigger Extracellular Matrix Remodeling in Keratoconus.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Keratoconus (KC) is a multifactorial corneal degenerative disorder characterized by reduced extracellular matrix (ECM) and cellular content. This study investigates the role and mechanism of cellular communication network factor 1 (CCN1) in KC progression. Methods: The expression of CCN1 was first examined in clinical samples using Western blot and immunofluorescence staining. A CCN1 overexpression cell model (OE CCN1) was then established by transfecting primary corneal stromal cells with CCN1 OE plasmids, and RNA sequencing was performed to identify downstream molecular pathways regulated by CCN1. Subsequently, multiple methodologies, including SA‑β‑Gal staining, enzyme‑linked immunosorbent assay (ELISA), qRT‑PCR, Western blot, immunofluorescence staining, flow cytometry, and transmission electron microscopy (TEM), were used to systematically evaluate the role of CCN1 in KC samples and corneal stromal cells. Results: CCN1 expression was significantly elevated in patients with KC. CCN1 OE markedly upregulated senescence and inflammatory pathways, increased expression of γH2AX, p16, p21, p53, and senescence-associated secretory phenotype (SASP) molecules. Additionally, CCN1 led to reactive oxygen species (ROS) accumulation, G2/M phase cell cycle arrest, enhanced apoptosis, lysosomal dysfunction, and matrix metalloproteinases (MMPs) OE, collectively contributing to ECM remodeling. Conclusions: CCN1 plays a critical role in promoting corneal degeneration in KC and may serve as a potential therapeutic target to halt or slow disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.